Literature DB >> 22108049

Fatal Neisseria meningitidis serogroup X sepsis in immunocompromised patients in Spain. Virulence of clinical isolates.

Diego Vicente1, Olatz Esnal, Emilio Pérez-Trallero.   

Abstract

BACKGROUND: Neisseria meningitidis X (NmX) is a minority meningococcus serogroup for which no vaccine is available. Huge meningococcus X outbreaks occurred in West Africa but developed countries have reported only sporadic cases. Two invasive fatal cases are presented.
METHODS: Isolates were characterized by serogrouping (latex agglutination and genogroup X-specific polymerase-chain-reaction), PorA and FetA typing, multilocus sequence typing and pulsed-field gel electrophoresis. Immunocompetent female balm/C mice inoculated intraperitoneally were use to test virulence of invasive and carrier isolates.
RESULTS: Until April 2010, NmX was absent among 868 invasive meningococci characterized in the Basque Country in a 20-year period. In April 2010, two fatal NmX: P1.21,16: F5-5/ST750 episodes were detected in unrelated immunodeficient patients. After analysis of 803 meningococcal isolates from asymptomatic carriers obtained between 1988 and 2010, eight NmX isolates were detected. The genotype of the two invasive isolates bore no relation to any of the NmX isolates detected in healthy individuals from the Basque Country or to isolates from outbreaks in Africa.
CONCLUSIONS: NmX isolates in the north of Spain can cause severe disease in humans, despite their low prevalence. The in vivo animal study showed that virulence of isolates was more closely associated with the genotype than with the serogroup.
Copyright © 2011 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22108049     DOI: 10.1016/j.jinf.2011.11.009

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  3 in total

1.  Invasive potential of nonencapsulated disease isolates of Neisseria meningitidis.

Authors:  Kay O Johswich; Jianwei Zhou; Dennis K S Law; Frank St Michael; Shannon E McCaw; Frances B Jamieson; Andrew D Cox; Raymond S W Tsang; Scott D Gray-Owen
Journal:  Infect Immun       Date:  2012-04-16       Impact factor: 3.441

2.  Meningococci of Serogroup X Clonal Complex 181 in Refugee Camps, Italy.

Authors:  Paola Stefanelli; Arianna Neri; Paola Vacca; Damiano Picicco; Laura Daprai; Giulia Mainardi; Gian Maria Rossolini; Alessandro Bartoloni; Anna Anselmo; Andrea Ciammaruconi; Antonella Fortunato; Anna Maria Palozzi; Silvia Fillo; Marino Faccini; Sabrina Senatore; Florigio Lista; Cecilia Fazio
Journal:  Emerg Infect Dis       Date:  2017-05       Impact factor: 6.883

3.  An efficient cell free enzyme-based total synthesis of a meningococcal vaccine candidate.

Authors:  Timm Fiebig; Maria Rosaria Romano; Davide Oldrini; Roberto Adamo; Marta Tontini; Barbara Brogioni; Laura Santini; Monika Berger; Paolo Costantino; Francesco Berti; Rita Gerardy-Schahn
Journal:  NPJ Vaccines       Date:  2016-11-15       Impact factor: 7.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.